IP Group Plc (LON: IPO)
London
· Delayed Price · Currency is GBP · Price in GBX
42.05
+2.45 (6.19%)
Nov 21, 2024, 4:52 PM BST
IP Group Company Description
IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies.
It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies.
The firm prefers to invest in Europe. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million).
IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong S.A.R., Hong Kong and Melbourne, Australia.
IP Group Plc
Country | United Kingdom |
Founded | 2001 |
Industry | Asset Management |
Sector | Financials |
Employees | 95 |
CEO | Gregory Smith |
Contact Details
Address: 2nd Floor London, N1C 4AG United Kingdom | |
Phone | 44 20 7444 0050 |
Website | ipgroupplc.com |
Stock Details
Ticker Symbol | IPO |
Exchange | London Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | GBP |
ISIN Number | GB00B128J450 |
SIC Code | 6799 |
Key Executives
Name | Position |
---|---|
Gregory Simon Smith A.C.A. | Chief Executive Officer and Executive Director |
David Graham Baynes | Chief Operating Officer, Chief Financial Officer, Executive Director and Operating Officer |
Eoin Murphy | Group Head of IT and Operations |
Angela Leach | General Counsel and Company Secretary |
Helen Redmond | Senior Compliance and Risk Manager |
Liz Vaughan-Adams | Director of Communications |
Anthony York | Group People Director |
Stuart Thompson | Talent Partner and Head of IP Exec |
Dr. Mark Alexander Reilly Ph.D. | Managing Partner of Technology, MD of Tech Investment Partnership and Board Observer |
Dr. Samuel Cameron Williams M.A., Ph.D. | Managing Partner, Head of Life Sciences, Managing Partner of Life Sciences and Board Observer |